Who is the spokesperson for cymbalta

Vote count: 1. No votes so far! Be the first to rate this post. Print This Page. How useful was this post? Click on a star to rate it! As you found this post useful Follow us on social media!

We are sorry that this post was not useful for you! Let us improve this post! Tell us how we can improve this post? Submit Feedback.

The cuts will reportedly be made by July 1, in order to place the company in better stead for coping with the looming loss of US patent protection for another two of its big sellers - the antidepressant Cymbalta duloxetine and the osteoporosis drug Evista raloxifene.

Free news subscriptions Free RSS feeds. Lilly to trim US salesforce 12th April Zyprexa loss hurts Lilly but forecast upped.

Lilly upbeat about prospects for and beyond. Pharmaceutical industry officials have said that insurers or other groups could use DURs to encourage doctors to use lower-cost drugs that might not be as effective. The Cymbalta contract also restricts "negative educational counterdetailing," a practice often used by insurers to counterbalance a drug maker's sales pitch to doctors that can focus on recommending generic drugs.

Reaction Tarra Ryker, a spokesperson for Lilly, said the Cymbalta contract was not meant to stop communications that are "backed up by clinical data" and "presented in a fair and balanced manner. Mohit Ghose, a spokesperson for America's Health Insurance Plans , said, "The signing of contracts does not in any way interfere with the ability of clinicians at insurance companies to discuss or disseminate information on the appropriateness, efficacy and safety of any given drug.